EDX Medical to Market Pioneering Cancer Drugs Response Assay in UK and Nordics

Contributed by: Business Wire

Tags

Technology
Medical Devices
Genetics
Clinical Trials
Health Technology
Biotechnology
Pharmaceutical
Health
Oncology
Artificial Intelligence
Curesponse Ltd

More Like This

Business Wire logo

EDX Medical Announces Agreement With Caris Life Sciences to Distribute Molecular Profiling in the United Kingdom and Nordic Countries

PR Newswire associated0

EDX MEDICAL ANNOUNCES COLLABORATION WITH THERMO FISHER SCIENTIFIC TO DEVELOP INNOVATIVE CANCER TESTS FOR GLOBAL HEALTHCARE MARKETS

Business Wire logo

New ‘Super Test’ for Prostate Cancer Developed in the UK by EDX Medical

Medical Boost for Young Men as New, Highly Accurate Early Detection Testicular Cancer Test Launched by EDX Medical in UK

NEW TESTS TO IDENTIFY HEREDITARY CANCER RISKS TO BE LAUNCHED

PR Newswire associated0

SCIENTISTS PIONEER DEVELOPMENT OF MULTI-DISEASE RAPID TESTS AS EDX MEDICAL PLC COMPLETES ACQUISITION OF HUTANO DIAGNOSTICS LTD

Business Wire logo

Exscientia Initiates Clinical Study to Further Evaluate Functional Precision Medicine Platform in Cancer Patients

Business Wire logo

Oxford BioDynamics part of consortium shortlisted for Strategic Government Initiative to Improve Cancer Immunotherapy